My NCBISign In
Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ
Ruria Namba, Lawrence JT Young, Jeannie E Maglione, Erik T McGoldrick, Stephenie Liu, Gregory T Wurz, Michael W DeGregorio, Alexander D Borowsky, Carol L MacLeod, Robert D Cardiff, Jeffrey P Gregg
Breast Cancer Res. 2005; 7(6): R881–R889. Published online 2005 September 13. doi: 10.1186/bcr1317
PMCID:
PMC1410776
Abstract Full Text PDF–733K

Is Cited by the Following 8 Articles in this Archive:

Ospemifene and 4-Hydroxyospemifene Effectively Prevent and Treat Breast Cancer in the MTag.Tg Transgenic Mouse Model
Rebekah A. Burich, Jamie L. McCall, Neelima R. Mehta, Brittany E. Greenberg, Katie E. Bell, Stephen M. Griffey, Michael W. DeGregorio, Gregory T. Wurz
Menopause. Author manuscript; available in PMC 2013 January 1.
Published in final edited form as: Menopause. 2012 January; 19(1): 96–103. doi: 10.1097/gme.0b013e318223e82a
PMCID:
PMC3246110
Free in PMC on 2013/01/01
Choosing a Mouse Model: Experimental Biology in Context—The Utility and Limitations of Mouse Models of Breast Cancer
Alexander D. Borowsky
Cold Spring Harb Perspect Biol. 2011 September; 3(9): a009670. doi: 10.1101/cshperspect.a009670
PMCID:
PMC3181037
Free in PMC on 2013/09/01
Adenosine A1 receptor, a target and regulator of ERα action, mediates the proliferative effects of estradiol in breast cancer
Zhihong Lin, Ping Yin, Scott Reierstad, Meghan O’Halloran, John S. Coon V, Elizabeth K. Pearson, Gökhan M. Mutlu, Serdar E. Bulun
Oncogene. Author manuscript; available in PMC 2010 August 25.
Published in final edited form as: Oncogene. 2010 February 25; 29(8): 1114–1122. Published online 2009 November 23. doi: 10.1038/onc.2009.409
PMCID:
PMC2829108
Abstract Full Text PDF–1.3M
Lessons in Signaling and Tumorigenesis from Polyomavirus Middle T Antigen
Michele M. Fluck, Brian S. Schaffhausen
Microbiol Mol Biol Rev. 2009 September; 73(3): 542–563. doi: 10.1128/MMBR.00009-09
PMCID:
PMC2738132
Abstract Full Text PDF–1.2M
Adiponectin-deficiency limits tumor vascularization in the MMTV-PyV-mT mouse model of mammary cancer
Martin S. Denzel, Lionel W. Hebbard, Gregory Shostak, Lawrence Shapiro, Robert D. Cardiff, Barbara Ranscht
Clin Cancer Res. Author manuscript; available in PMC 2010 July 16.
Published in final edited form as: Clin Cancer Res. 2009 May 15; 15(10): 3256–3264. Published online 2009 May 15. doi: 10.1158/1078-0432.CCR-08-2661
PMCID:
PMC2905461
Abstract Full Text PDF–718K Supplementary Material
Prevention of tumorigenesis in p53 null mammary epithelium by rexinoid bexarotene, tyrosine kinase inhibitor gefitinib and celecoxib
D. Medina, F. Kittrell, J. Hill, Y. Zhang, S. Hilsenbeck, R. Bissonette, P.H. Brown
Cancer Prev Res (Phila) Author manuscript; available in PMC 2010 December 1.
Published in final edited form as: Cancer Prev Res (Phila). 2009 February; 2(2): 168–174. Published online 2009 January 27. doi: 10.1158/1940-6207.CAPR-08-0107
PMCID:
PMC2995265
Abstract Full Text PDF–130K
New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer
V. Craig Jordan
Steroids. Author manuscript; available in PMC 2009 September 9.
Published in final edited form as: Steroids. 2007 November; 72(13): 829–842. Published online 2007 July 27. doi: 10.1016/j.steroids.2007.07.009
PMCID:
PMC2740485
Abstract Full Text PDF–871K
Heterogeneity of mammary lesions represent molecular differences
Ruria Namba, Jeannie E Maglione, Ryan R Davis, Colin A Baron, Stephenie Liu, Condie E Carmack, Lawrence JT Young, Alexander D Borowsky, Robert D Cardiff, Jeffrey P Gregg
BMC Cancer. 2006; 6: 275. Published online 2006 December 5. doi: 10.1186/1471-2407-6-275
PMCID:
PMC1762020
Abstract Full Text PDF–1.0M Supplementary Material
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk